Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1.
Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant predisposition to neoplastic lesions of the parathyroid glands, the neuroendocrine pancreas, and the anterior pituitary gland. The predisposing genetic defect was localized to the long arm of chromosome 11 by genetic linkage analysis in three affected families. By analyzing six MEN 1 families with 14 DNA marker systems located close to the MEN 1 gene, we have developed a method to identify carriers of the MEN 1 predisposition. We describe practical aspects of such DNA-based diagnostic procedures.
Larsson
C
C
Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden.
Nordenskjold
M
M
Skogseid
B
B
Oberg
K
K
D015139:Blotting, Southern; D002874:Chromosome Mapping; D002880:Chromosomes, Human, Pair 11; D015342:DNA Probes; D004273:DNA, Neoplasm / Q000235:genetics; D006580:Genetic Carrier Screening; D005819:Genetic Markers; D006801:Humans; D009377:Multiple Endocrine Neoplasia / Q000175:diagnosis* / Q000235:genetics; D011110:Polymorphism, Genetic
D015342:DNA Probes; D004273:DNA, Neoplasm; D005819:Genetic Markers